Application of Artificial Intelligence in Precision Medicine and Healthcare

NCT06879210 | Recruiting

• 1 other identifier: 20221210R
• Study Type: interventional
• Target: 10
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to propose an intelligent health robot that utilizes remote intelligent robots to assist patients with disease-related issues, enabling them to address their problems promptly.

Conditions

Myasthenia Gravis

Keywords

Myasthenia Gravis; AI

Outcome Measures

Primary Outcomes (1)

• Can the use of a mobile device [Disease Assistance Consultation] enhance the understanding of disease care and increase knowledge related to diseases in traditional Chinese medicine?

  Each patient will be followed up after using the application system for 4 weeks. Each patient will be interviewed for 20 minutes, and the data will be compiled and written later.

  4 weeks

Study Arms (1)

Disease Group

OTHER

In this study, patients with myasthenia gravis will be used as an example. After the patients use this disease inquiry platform, researchers will conduct interviews with them to understand their experiences and feedback.

Device: Mobile device.(phone)

Interventions

Mobile device.(phone) DEVICE

Develop a mobile device \[Disease Assistance Consultation\] to help patients promptly understand their disease and how to care for it. After a 4-week trial period, conduct interviews with participants to determine whether using the mobile device can increase participants' knowledge and improve the quality of healthcare.

Disease Group

Eligibility Criteria

• Age: 20 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients diagnosed with myasthenia gravis by a physician.
• Age 20 years and above.
• Able to use a smartphone.

You may not qualify if:

• Individuals not diagnosed with myasthenia gravis.
• Individuals who do not use smartphones or tablets.
• Individuals who withdraw from the group midway.
• Individuals unwilling to participate in interviews.

Sponsors & Collaborators

• Yi Ting Yeh: lead

Study Sites (1)

Yi Ting Yeh

New Taipei City, Tamsui District, 251, Taiwan

RECRUITING

MeSH Terms

Conditions

Myasthenia Gravis

Condition Hierarchy (Ancestors)

Paraneoplastic Syndromes, Nervous System; Nervous System Neoplasms; Neoplasms by Site; Neoplasms; Paraneoplastic Syndromes; Autoimmune Diseases of the Nervous System; Nervous System Diseases; Neurodegenerative Diseases; Neuromuscular Junction Diseases; Neuromuscular Diseases; Autoimmune Diseases; Immune System Diseases

Central Study Contacts

YI TIMG YEH

CONTACT

+866-952-166-103; reinating90@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: DEVICE FEASIBILITY
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: August 10, 2024
• First Posted: March 17, 2025
• Study Start: April 19, 2023
• Primary Completion: April 19, 2026
• Study Completion (Estimated): July 19, 2026
• Last Updated: June 4, 2025

Record last verified: 2025-06

Locations

TW (1)